Small-cap and emerging markets tilts
A global tracker holds the world by market cap — ~70% US, ~25% other developed, ~5% emerging, with mostly large-caps. The academic literature (Fama-French and successors) argues small-cap and value factors deliver a long-run return premium. EM specifically has lower historical valuations and higher expected returns than developed markets. Whether to tilt — and how much — is one of the meaningful decisions UK retail investors actually face. Here's the honest case.
What "tilts" mean
A market-weight portfolio holds the global equity market as it is — 70% US, 4% UK, 10% emerging, etc. A "tilt" is an active overweight to a specific factor or region beyond what market-cap weighting would give you.
Common tilts:
- Small-cap tilt: overweight companies with smaller market capitalisation. The "size" factor in factor investing.
- Value tilt: overweight companies trading at low price/book or price/earnings ratios. The "value" factor.
- Emerging markets tilt: overweight EM equities beyond the ~10% market-weight allocation
- Quality tilt: overweight companies with high profitability and stable earnings
- Momentum tilt: overweight companies whose price has trended upward recently
For UK retail, the two most practical (i.e. cheap to implement) are small-cap and emerging markets. Value and quality require dedicated factor ETFs which tend to have higher OCFs and tighter holdings.
The academic case (briefly)
Eugene Fama and Kenneth French's 1992-1993 research identified two factors that explained equity returns beyond beta (market exposure):
- SMB (Small Minus Big): small caps outperformed large caps by ~3% per year on average from 1927-1990
- HML (High Minus Low): value stocks outperformed growth stocks by ~5% per year on average over the same period
The factor premia were larger than what could be explained by random variation, leading to the "small-cap premium" and "value premium" hypotheses. Later research found these premia were partly explained by additional risk — small caps are more sensitive to recessions; value stocks are typically more distressed.
Crucial nuance: the premia exist over very long periods but can underperform for decades. The small-cap premium was essentially absent or negative from 1990-2020. The value premium has been negative since 2007. Anyone tilting based on the academic theory needs to hold through multi-decade periods of underperformance.
The emerging-markets case (specifically)
EM is a slightly different argument from the size/value factors:
- Lower valuations: EM equities have historically traded at lower price/earnings multiples than developed markets (~12x vs ~18x in 2026). Lower starting valuations mean higher expected long-run returns — if earnings grow at the same rate.
- Faster economic growth: EM economies grow faster than developed markets. The translation from GDP growth to equity returns is imperfect (ownership claims dilute in fast-growing economies) but positive on average.
- Diversification: EM correlations with developed markets are below 1 (around 0.7-0.8). Including EM modestly reduces portfolio volatility per unit of return.
- Currency exposure: EM equity returns include exposure to EM currencies, which has been a drag (most EM currencies depreciated vs USD/GBP 2010-2020) but can swing positive in a USD-weakness regime.
The forward-looking case for EM is reasonable: ~3% per year of "extra expected return" vs developed markets is a common Vanguard / Morningstar projection for the next decade.
Practical implementation
Small-cap funds available to UK retail
| Ticker | Name | OCF | Coverage |
|---|---|---|---|
| WLDS | iShares MSCI World Small Cap UCITS | 0.35% | Developed market small-caps, ~4,400 companies |
| IDP6 | iShares Edge MSCI World Size Factor UCITS | 0.30% | Small/mid-cap tilt within developed markets |
| ZPRV | SPDR MSCI World Small Cap Value Weighted UCITS | 0.45% | Small + value double tilt |
| VBR | Vanguard US Small Cap Value (UK retail availability limited) | 0.20% | US small-cap value; popular Fama-French implementation |
EM funds available to UK retail
| Ticker | Name | OCF | Coverage |
|---|---|---|---|
| EIMI | iShares Core MSCI EM IMI UCITS | 0.18% | MSCI Emerging Markets including small-caps. ~3,200 names |
| VFEM | Vanguard FTSE Emerging Markets | 0.22% | FTSE EM index. ~1,700 names |
| EEM | iShares MSCI EM UCITS | 0.18% | Standard MSCI EM (large + mid cap only, no small-caps) |
| SEMA | iShares MSCI EM SRI UCITS | 0.25% | EM ex-fossil fuels & controversial sectors |
Example tilted portfolios
Modest tilt (most retail)
80% equity / 20% bond. Add 10% EM overweight on top of the natural EM weight in the global tracker.
- 72% VWRP (global, includes ~6-7% EM by default = ~5% of total portfolio in EM)
- 8% EIMI (additional EM = brings total EM to ~13% of portfolio = ~16% of equity)
- 20% AGGH
Net effect: about 1.6x EM overweight vs market cap. Modest, defensible.
Aggressive multi-factor tilt
80% equity / 20% bond. Heavy overweight to size + EM:
- 50% VWRP (large-cap core)
- 15% WLDS (developed small-caps overweight)
- 15% EIMI (EM overweight)
- 20% AGGH
Net effect: ~30% size + EM combined tilt. High conviction in academic factor premia. Higher expected return AND higher expected volatility.
Academic Fama-French style tilt
Some investors who fully buy the Fama-French model build "small value, large growth, EM, developed" baskets explicitly. This requires multiple ETFs (size + value + EM + core), higher OCF blend, and more rebalancing. Best suited to investors with very long horizons and full conviction.
Expected cost / benefit
If small-cap and EM premia deliver their long-run averages, a moderate tilt (10-15% extra weight) should add roughly 0.3-0.7% per year to long-run returns. On a £100k portfolio held for 30 years, that compounds to £30,000-£70,000 of extra wealth.
But the variance is huge. The premia can fail to deliver for decades; the additional volatility increases the chance of capitulation during the inevitable bad stretches. The tilt's expected return premium is real but not guaranteed.
The cost is structural: tilted portfolios have higher OCFs (small-cap funds 0.30-0.45%; EM funds 0.18-0.25% vs global 0.15-0.22%). On a 15% tilt, the blended OCF goes up by maybe 0.02-0.05% per year. Small.
When NOT to tilt
- Short horizon (<10 years): factor premia don't reliably show in short periods. The added volatility hurts more than the expected premium helps.
- Low risk tolerance: small-cap drawdowns can be 50%+; EM drawdowns can be 60%+. If you'd panic-sell at the bottom, the tilt costs you money.
- You're already heavily diversified globally: a global tracker like VWRP already includes ~12% small-cap by default (FTSE All-World extends to mid-caps but excludes pure small-caps). The "missing" small-cap exposure is smaller than people think.
- You're behaviourally inconsistent: if you'd abandon the tilt at the wrong time (rebalancing out of small-caps after they crash, or adding more after they soar), the tilt becomes a performance-chasing trap.
When tilting makes sense
- Long horizon (20+ years): enough time for the premia to play out
- Disciplined rebalancing: you'll rebalance INTO the underperformer when it drops, not OUT of it
- High academic conviction: you've read the Fama-French papers and the rebuttals, and you've concluded the premia are real-enough to bet on
- Aware of the costs: you accept slightly higher OCF, higher volatility, and potential multi-decade underperformance periods
- Already at "good enough" baseline: you have a globally-diversified core (VWRP or equivalent), bond allocation, emergency fund. Tilts are a refinement on top of fundamentals, not a substitute for them.
Frequently asked questions
Is small-cap dead as a factor?
The small-cap premium has been muted for 30+ years and absent for the last 15. Some academic researchers (Fama himself in recent papers) have suggested the original effect was a data anomaly or has been arbitraged away. Others maintain it's still a real long-run premium that just hasn't shown in recent periods. The honest answer: nobody knows. Tilt at your own conviction.
What about China specifically?
China is ~25-30% of MSCI EM and ~3% of MSCI ACWI. An EM tilt is significantly a China tilt. If you have specific views on China (positive or negative), this matters. Some investors prefer "EM ex-China" tilts (e.g. IEMG ex-China share classes) to express EM exposure without the China concentration.
Does Vanguard / iShares recommend tilts?
Vanguard's house view is market-weight equity allocation (no factor tilts). Their LifeStrategy doesn't include factor tilts. iShares offers a wide range of factor ETFs (Edge series) and doesn't strongly recommend tilts either way — they make products for whichever view investors want to express.
What about value tilts?
The value premium has been negative since 2007 — growth stocks (especially US tech) have crushed value for 15+ years. Some argue this means value is overdue for a strong period; others argue the premium has structurally disappeared. Implementation is harder (value ETFs use different definitions; iShares Edge MSCI World Value vs Avantis vs Dimensional all differ). For UK retail, value tilts are a smaller share of factor allocations than EM and small-cap.
How often should I rebalance tilts?
Annual rebalancing is fine for most retail. The danger with frequent rebalancing is performance-chasing — selling losers and buying winners just as the underperformer is about to revert. Mechanical annual rebalancing avoids this trap.
Related guides
How UK Tax Drag holds itself to account
Every page is reviewed against the editorial standards, written from primary sources, sourced openly, and corrected publicly. No affiliate revenue. No sponsored content. No paid placements.